decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
Appendix E - National Coverage Determinations Manual / COLORECTAL_CANCER_SCREENING
Subscribe or sign in to view the full article.
Article Overview
This article explains Medicare’s national coverage framework for colorectal cancer screening within the National Coverage Determinations Manual. It is relevant to coders, billing staff, compliance teams, and clinicians who need to understand the broad categories of screening services covered, the timing and age parameters described in the guidance, and the regulatory changes that affected fecal occult blood testing. The article also distinguishes covered and noncovered screening indications and notes the CMS rulemaking context behind the policy.
Why This Topic Matters
Colorectal cancer screening coverage rules affect whether preventive services are payable under Medicare and how screening test categories are recognized in policy. Understanding this guidance helps organizations align documentation, scheduling, and billing practices with current national coverage requirements.
Article Sections
-
Colorectal Cancer Screening Tests 210.3
Overview of Medicare’s national coverage framework for colorectal cancer screening and the screening test categories addressed in the manual entry.
-
Covered Indications
General coverage guidance describing the screening services included under Medicare and the scope of the covered indication categories.
-
History
Background discussion of fecal occult blood testing terminology, test types, and the CMS rulemaking context referenced in the article.
-
Expanded Coverage
Summary of the broadened Medicare screening coverage for fecal occult blood testing, including the general frequency and beneficiary criteria described in the policy.
-
Noncovered Indications
Statement of screening indications that remain outside coverage when not otherwise specified in the guidance.
What You Will Learn
- How Medicare frames coverage for colorectal cancer screening services
- What general screening test categories are addressed in the policy
- How the article situates fecal occult blood testing within CMS rulemaking
- What broad coverage and noncoverage sections the manual entry contains
- Which organizations and regulatory sources are referenced in the coverage discussion
Who Should Read This
- Medical coders
- Billing specialists
- Compliance staff
- Revenue cycle teams
- Clinicians involved in preventive screening
- Health information management professionals
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com